Rohto Pharmaceutical Co.,Ltd. (TYO:4527)

Market Cap	538.02B -0.2%
Revenue (ttm)	343.73B +11.4%
Net Income	34.25B +10.5%
EPS	145.29 +7.3%
Shares Out	225.96M
PE Ratio	16.39
Forward PE	15.62
Dividend	50.00 (2.01%)
Ex-Dividend Date	Mar 30, 2026

Volume	1,826,300
Open	2,465.50
Previous Close	2,483.00
Day's Range	2,381.00 - 2,485.50
52-Week Range	1,964.50 - 2,703.00
Beta	-0.47
Analysts	Buy
Price Target	2,907.27 (+22.1%)
Earnings Date	May 13, 2026

About Rohto Pharmaceutical

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatologi...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1899
• Employees: 9,144
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4527

Financial Performance

In fiscal year 2026, Rohto Pharmaceutical's revenue was 343.73 billion, an increase of 11.37% compared to the previous year's 308.63 billion. Earnings were 34.25 billion, an increase of 10.45%.